329 related articles for article (PubMed ID: 33432333)
1. Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC).
Zito C; Manganaro R; Cusmà Piccione M; Madonna R; Monte I; Novo G; Mercurio V; Longobardo L; Cadeddu Dessalvi C; Deidda M; Pagliaro P; Spallarossa P; Costantino R; Santarpia M; Altavilla G; Carerj S; Tocchetti CG
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):406-415. PubMed ID: 33432333
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
[TBL] [Abstract][Full Text] [Related]
4. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy.
Anqi Y; Yu Z; Mingjun X; Xiaoli K; Mengmeng L; Fangfang L; Mei Z
Echocardiography; 2019 Mar; 36(3):495-502. PubMed ID: 30636342
[TBL] [Abstract][Full Text] [Related]
5. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy.
Thavendiranathan P; Negishi T; Coté MA; Penicka M; Massey R; Cho GY; Hristova K; Vinereanu D; Popescu BA; Izumo M; Negishi K; Marwick TH;
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1109-1118. PubMed ID: 29778856
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients.
Mele D; Malagutti P; Indelli M; Ferrari L; Casadei F; Da Ros L; Pollina A; Fiorencis A; Frassoldati A; Ferrari R
Ultrasound Med Biol; 2016 Jan; 42(1):125-32. PubMed ID: 26603736
[TBL] [Abstract][Full Text] [Related]
7. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
[TBL] [Abstract][Full Text] [Related]
8. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.
Negishi K; Negishi T; Haluska BA; Hare JL; Plana JC; Marwick TH
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):324-31. PubMed ID: 24057661
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of left ventricular global longitudinal strain on speckle echocardiography for predicting chemotherapy-induced cardiotoxicity in breast cancer patients: A systematic review and meta-analysis.
Li L; Jiang X; Xie Q
Echocardiography; 2023 Apr; 40(4):306-317. PubMed ID: 36859694
[TBL] [Abstract][Full Text] [Related]
10. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
[TBL] [Abstract][Full Text] [Related]
11. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial.
Negishi T; Thavendiranathan P; Penicka M; Lemieux J; Murbraech K; Miyazaki S; Shirazi M; Santoro C; Cho GY; Popescu BA; Kosmala W; Costello B; la Gerche A; Mottram P; Thomas L; Seldrum S; Hristova K; Bansal M; Kurosawa K; Fukuda N; Yamada H; Izumo M; Tajiri K; Sinski M; Vinereanu D; Shkolnik E; Banchs J; Kutty S; Negishi K; Marwick TH
JACC Cardiovasc Imaging; 2023 Mar; 16(3):269-278. PubMed ID: 36435732
[TBL] [Abstract][Full Text] [Related]
13. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.
Thavendiranathan P; Negishi T; Somerset E; Negishi K; Penicka M; Lemieux J; Aakhus S; Miyazaki S; Shirazi M; Galderisi M; Marwick TH;
J Am Coll Cardiol; 2021 Feb; 77(4):392-401. PubMed ID: 33220426
[TBL] [Abstract][Full Text] [Related]
14. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy.
El-Sherbeny WS; Sabry NM; Sharbay RM
J Echocardiogr; 2019 Jun; 17(2):76-83. PubMed ID: 30099714
[TBL] [Abstract][Full Text] [Related]
15. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
Tang Q; Jiang Y; Xu Y; Xia H
J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
17. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L
PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011
[TBL] [Abstract][Full Text] [Related]
18. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):392-401. PubMed ID: 28064155
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
[TBL] [Abstract][Full Text] [Related]
20. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
